An economon model of drug addiction
Article Properties
-
LanguageEnglish
-
DOI (url)
-
Publication Date2024/01/26
-
Journal
-
Indian UGC (journal)
-
Refrences51
-
S. Stevens Negus ORCID (unauthenticated)
Abstract
Cite
Negus, S. Stevens. “An Economon Model of Drug Addiction”. Psychopharmacology, vol. 241, no. 3, 2024, pp. 417-25, https://doi.org/10.1007/s00213-024-06535-7.
Negus, S. S. (2024). An economon model of drug addiction. Psychopharmacology, 241(3), 417-425. https://doi.org/10.1007/s00213-024-06535-7
Negus, S. Stevens. “An Economon Model of Drug Addiction”. Psychopharmacology 241, no. 3 (2024): 417-25. https://doi.org/10.1007/s00213-024-06535-7.
1.
Negus SS. An economon model of drug addiction. Psychopharmacology. 2024;241(3):417-25.
Journal Categories
Medicine
Internal medicine
Neurosciences
Biological psychiatry
Neuropsychiatry
Medicine
Internal medicine
Neurosciences
Biological psychiatry
Neuropsychiatry
Neurology
Diseases of the nervous system
Psychiatry
Medicine
Therapeutics
Pharmacology
You May Also Like
- Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: A novel test of anxiety in the rat
- Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines
- A review of the validity and variability of the Elevated Plus-Maze as an animal model of anxiety
- REVIEW ON CPP: Measuring reward with the conditioned place preference (CPP) paradigm: update of the last decade
- Impulsivity as a determinant and consequence of drug use: a review of underlying processes
Refrences
| Title | Journal | Journal Categories | Citations | Publication Date |
|---|---|---|---|---|
| Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development | Pharmacological Reviews |
| 135 | 2021 |
Systematic review of Pharmacogenomics Knowledgebase evidence for pharmacogenomic links to the dopamine reward pathway for heroin dependence | Pharmacogenomics |
| 2 | 2021 |
The role of social isolation in opioid addiction | Social Cognitive and Affective Neuroscience |
| 29 | 2021 |
| Medications Development for Treatment of Opioid Use Disorder | Cold Spring Harbor Perspectives in Medicine |
| 7 | 2021 |
| Preclinical Evaluation of Vaccines to Treat Opioid Use Disorders: How Close are We to a Clinically Viable Therapeutic? | CNS Drugs |
| 15 | 2020 |
Refrences Analysis
The category
Medicine: Internal medicine: Neurosciences. Biological psychiatry. Neuropsychiatry 21
is the most frequently represented among the references in this article. It primarily includes studies from Trends in Pharmacological Sciences and Pharmacological Reviews. The chart below illustrates the number of referenced publications per year.